Skip to main content
. 2023 Nov 29;4(4):102758. doi: 10.1016/j.xpro.2023.102758

Table 3.

Recommend agonist concentrations to be used for inhibitor screening

Cell type/Target receptor Endogenous agonist Concentration (1 X)
CHO-C5aR1 hC5a 0.3 nM
CHO-C3aR hC3a 0.3 nM
HMDM (C5aR1) hC5a 1 nM
HMDM (C3aR) hC3a 5 nM